Bull
$0.10
Scenario price
$5.200
+2.504 (+48.15%)At close
Q/C Technologies, Inc., formerly TNF Pharmaceuticals, Inc., is focused on blockchain infrastructure. The Company, through a licensing agreement with LightSolver, holds rights to the use of quantum-inspired laser-based processing units (LPUs) that solve compute-intensive combinatorial and physical problems at the speed of light. The Company bridges a disruptive computing paradigm for high-speed photonic computing with cryptocurrency infrastructure development at scale, enabling performance and sustainability for blockchain applications. Lightsolver’s architecture is designed to improve security for blockchain operations for the cryptocurrency industry.
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Q/C Technologies (Previously TNF Pharmaceuticals) Begins Trading on Nasdaq with New Ticker Symbol "QCLS"

TNF Pharmaceuticals Reveals Rebranding to Q/C Technologies

TNF Pharmaceuticals Rebrands as Q/C Technologies and Adopts New Ticker Symbol "QCLS" to Align with Quantum Class Photonic Computing Strategy

TNF Pharmaceuticals to Showcase at the 27th Annual Global Investment Conference Hosted by H.C. Wainwright

TNF Pharmaceuticals Completes $7 Million Private Placement Financing
Q/C Technologies, Inc., formerly TNF Pharmaceuticals, Inc., is focused on blockchain infrastructure. The Company, through a licensing agreement with LightSolver, holds rights to the use of quantum-inspired laser-based processing units (LPUs) that solve compute-intensive combinatorial and physical problems at the speed of light. The Company bridges a disruptive computing paradigm for high-speed photonic computing with cryptocurrency infrastructure development at scale, enabling performance and sustainability for blockchain applications. Lightsolver’s architecture is designed to improve security for blockchain operations for the cryptocurrency industry. It operates in the Healthcare sector.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.